Aerie Pharma (AERI) Tops Q2 EPS by 2c

Aerie Pharma (NASDAQ: AERI) reported Q2 EPS of ($0.72), $0.02 better than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
• UBS Downgrades Core Natural Resources (CNR) to Neutral